Find clinical trials for Acute Myeloid Leukemia (AML) in Louisville, KY
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Acute Myeloid Leukemia (AML) trials near Louisville, KY, USA:
Ziftomenib is an investigational drug in development for the treatment of patients with acute myeloid leukemia (AML...
Phase 1
Louisville, Kentucky, United States and 43 other locations
\[GO\]) improves survival of children/adolescents/young adults with acute myeloid leukemia (AML) in 1st relapse w...
Phase 3
Louisville, Kentucky, United States and 88 other locations
VEN+AZA alone for the treatment of participants with newly diagnosed Acute Myeloid Leukemia (AML) with a mutation...
Phase 3
Louisville, Kentucky, United States and 238 other locations
Acute Myeloid Leukaemia (AML) is an aggressive and rare cancer of myeloid cells (a white blood cell responsible f...
Phase 3
Louisville, Kentucky, United States and 171 other locations
The purpose of the study is to characterize safety and tolerability of cusatuzumab in combination with various therapies used to treat acute ...
Phase 1
Louisville, Kentucky, United States and 22 other locations
drug cusatuzumab added to venetoclax and azacitidine works to treat acute myeloid leukemia (AML) compared to vene...
Phase 2
Louisville, Kentucky, United States and 30 other locations
with intensive chemotherapy in participants with newly diagnosed acute myeloid leukemia (AML) harboring alteratio...
Phase 1
Louisville, Kentucky, United States and 45 other locations
it is safe for participants with myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). It will study S...
Phase 1
Louisville, Kentucky, United States and 55 other locations
to venetoclax for patients with CD33 positive relapsed/refractory AML. (Phase 1 portion)2. To assess the percentage of patients with CR, CRh...
Phase 1, Phase 2
Louisville, Kentucky, United States and 4 other locations
The purpose of this study is to test the safety of an investigational drug called CFI-400945 alone and in combination with azacitidine.
Phase 1, Phase 2
Louisville, Kentucky, United States and 8 other locations
Clinical trials
Research sites
Resources
Legal